ISO-690 (author-date, English)

GOESER, Felix, SIFFT, Barbara, STEIN-THÖRINGER, Christoph, FAROWSKI, Fedja, STRASSBURG, Christian P., BROSSART, Peter, HIGGINS, Paul G., SCHEID, Christoph, WOLF, Dominik, HOLDERRIED, Tobias Albert Wilhelm, VEHRESCHILD, Maria J. G. T. und CRUZ AGUILAR, Marta Rebeca, 2021. Fecal microbiota transfer for refractory intestinal graft-versus-host disease — experience from two German tertiary centers. Oxford: Wiley-Blackwell.

Elsevier - Harvard (with titles)

Goeser, F., Sifft, B., Stein-Thöringer, C., Farowski, F., Straßburg, C.P., Brossart, P., Higgins, P.G., Scheid, C., Wolf, D., Holderried, T.A.W., Vehreschild, M.J.G.T., Cruz Aguilar, M.R., 2021. Fecal microbiota transfer for refractory intestinal graft-versus-host disease — experience from two German tertiary centers, European journal of haematology. Wiley-Blackwell, Oxford. https://doi.org/10.1111/ejh.13642

American Psychological Association 7th edition

Goeser, F., Sifft, B., Stein-Thöringer, C., Farowski, F., Straßburg, C. P., Brossart, P., Higgins, P. G., Scheid, C., Wolf, D., Holderried, T. A. W., Vehreschild, M. J. G. T., & Cruz Aguilar, M. R. (ca. 2021). Fecal microbiota transfer for refractory intestinal graft-versus-host disease — experience from two German tertiary centers [Cd]. In European journal of haematology. Wiley-Blackwell. https://doi.org/10.1111/ejh.13642

Springer - Basic (author-date)

Goeser F, Sifft B, Stein-Thöringer C, Farowski F, Straßburg CP, Brossart P, Higgins PG, Scheid C, Wolf D, Holderried TAW, Vehreschild MJGT, Cruz Aguilar MR (2021) Fecal microbiota transfer for refractory intestinal graft-versus-host disease — experience from two German tertiary centers. Wiley-Blackwell, Oxford

Juristische Zitierweise (Stüber) (Deutsch)

Goeser, Felix/ Sifft, Barbara/ Stein-Thöringer, Christoph/ Farowski, Fedja/ Straßburg, Christian P./ Brossart, Peter/ Higgins, Paul G./ Scheid, Christoph/ Wolf, Dominik/ Holderried, Tobias Albert Wilhelm/ Vehreschild, Maria J. G. T./ Cruz Aguilar, Marta Rebeca, Fecal microbiota transfer for refractory intestinal graft-versus-host disease — experience from two German tertiary centers, Oxford 2021.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.